D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+4.83%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$59.1B
AUM Growth
+$2.16B
Cap. Flow
-$6.66B
Cap. Flow %
-11.27%
Top 10 Hldgs %
12.26%
Holding
4,263
New
334
Increased
1,320
Reduced
1,181
Closed
606

Sector Composition

1 Technology 20.4%
2 Healthcare 13.71%
3 Financials 11.95%
4 Consumer Discretionary 11.45%
5 Industrials 7.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HOMB icon
1751
Home BancShares
HOMB
$5.89B
$2.52M ﹤0.01%
110,746
-99,104
-47% -$2.26M
SITM icon
1752
SiTime
SITM
$6.76B
$2.52M ﹤0.01%
24,815
+11,513
+87% +$1.17M
NKGN
1753
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$2.51M ﹤0.01%
252,656
RAPT icon
1754
RAPT Therapeutics
RAPT
$268M
$2.51M ﹤0.01%
15,838
+3,403
+27% +$539K
PLXS icon
1755
Plexus
PLXS
$3.73B
$2.51M ﹤0.01%
24,349
+17,927
+279% +$1.85M
DIN icon
1756
Dine Brands
DIN
$368M
$2.51M ﹤0.01%
38,785
+32,330
+501% +$2.09M
STAA icon
1757
STAAR Surgical
STAA
$1.37B
$2.5M ﹤0.01%
51,496
+2,598
+5% +$126K
AOUT icon
1758
American Outdoor Brands
AOUT
$111M
$2.5M ﹤0.01%
249,376
-23,467
-9% -$235K
RDFN
1759
DELISTED
Redfin
RDFN
$2.5M ﹤0.01%
+588,676
New +$2.5M
KNDI
1760
Kandi Technologies Group
KNDI
$112M
$2.49M ﹤0.01%
1,084,743
+57,894
+6% +$133K
INBX
1761
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2.49M ﹤0.01%
101,240
+31,521
+45% +$777K
CLBK icon
1762
Columbia Financial
CLBK
$1.6B
$2.49M ﹤0.01%
115,341
-42,068
-27% -$910K
SBGI icon
1763
Sinclair Inc
SBGI
$972M
$2.49M ﹤0.01%
160,666
-158,992
-50% -$2.47M
BLKB icon
1764
Blackbaud
BLKB
$3.38B
$2.49M ﹤0.01%
42,327
-1,309
-3% -$77K
QOMO
1765
DELISTED
Qomolangma Acquisition Corp. Common Stock
QOMO
$2.48M ﹤0.01%
+247,500
New +$2.48M
QDRO
1766
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$2.48M ﹤0.01%
245,336
HLX icon
1767
Helix Energy Solutions
HLX
$914M
$2.48M ﹤0.01%
335,497
+214,847
+178% +$1.59M
SANA icon
1768
Sana Biotechnology
SANA
$828M
$2.47M ﹤0.01%
626,197
+89,480
+17% +$353K
OWL icon
1769
Blue Owl Capital
OWL
$12.2B
$2.47M ﹤0.01%
+232,818
New +$2.47M
EONR
1770
EON Resources Inc.
EONR
$13.8M
$2.46M ﹤0.01%
240,900
AVDL
1771
Avadel Pharmaceuticals
AVDL
$1.5B
$2.46M ﹤0.01%
343,755
-8,359
-2% -$59.9K
ERIE icon
1772
Erie Indemnity
ERIE
$17.7B
$2.45M ﹤0.01%
9,857
+5,881
+148% +$1.46M
GBDC icon
1773
Golub Capital BDC
GBDC
$3.93B
$2.45M ﹤0.01%
185,885
+173,218
+1,367% +$2.28M
NOV icon
1774
NOV
NOV
$4.79B
$2.44M ﹤0.01%
116,963
+89,060
+319% +$1.86M
SFBS icon
1775
ServisFirst Bancshares
SFBS
$4.57B
$2.44M ﹤0.01%
35,437
-11,220
-24% -$773K